Browse Medicine | Stanford Profiles

Angelica Aberia

Clinical Research Coordinator 2, Medicine - Med/Immunology & Rheumatology

Contact Info

Other Names:

Angie Aberia

BioDr. Anastasiou is a board-certified, fellowship-trained rheumatologist with the Stanford Health Care Immunology and Rheumatology Clinic. She is also a clinical assistant professor in the Department of Medicine, Division of Immunology and Rheumatology at Stanford University School of Medicine.

Dr. Anastasiou specializes in diagnosing and treating patients with rheumatic diseases. She has a special interest in ankylosing spondylitis, systemic lupus erythematosus, rheumatoid arthritis, and idiopathic inflammatory myopathies.

Her scholarly work includes epidemiologic studies and clinical trials focused on improving safety and health outcomes for people with chronic rheumatic diseases. Dr. Anastasiou has served as an investigator and collaborator for clinical trials of new therapies to treat rheumatic disease. She is actively involved in medical education through developing and leading patient, medical student, resident, and fellow educational programs.

Dr. Anastasiou is a member of the American College of Rheumatology (ACR). She has published her research in peer-reviewed journals, including Arthritis Care & Research and Lupus Science & Medicine. She has delivered lectures and presentations across the country and abroad on various topics related to rheumatology.

Matthew C. Baker, MD MS

Associate Professor of Medicine (Immunology and Rheumatology)

BioDr. Baker is an Associate Professor of Medicine and Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University. He is an internationally recognized expert in IgG4-related disease and is the Co-Founder and Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. Dr. Baker received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and a master's degree in Epidemiology and Clinical Research from Stanford University. He completed his residency in Internal Medicine at Massachusetts General Hospital and his fellowship in Rheumatology at Stanford University.

Dr. Baker's research program spans clinical trials, epidemiology, and translational science with the goal of accelerating the development of innovative therapies for immune-mediated diseases. He has designed and led investigator-initiated and industry-sponsored clinical trials in IgG4-related disease, sarcoidosis, Sjögren's disease, and rheumatoid arthritis. His epidemiologic research focuses on defining disease mechanisms, identifying novel therapeutic targets, and repurposing existing medications, including for the treatment of osteoarthritis.

Dr. Baker is also the Co-Founder and Co-Director of the Stanford Immune Reset Program, an interdisciplinary initiative dedicated to advancing transformative therapies with curative potential for autoimmune diseases, including T-cell engagers and in vivo CAR T-cell therapies.